Matthew Parker
Matt leads TTP’s work to define and develop innovative drug delivery systems. With a current focus on injectable therapies, he specialises in working with our clients at an early stage, bringing together the commercial case, technical feasibility, and user needs to define the right solutions to unlock pipeline therapies. With Masters in Mechanical Engineering from Cambridge, his work at TTP has included developing novel microneedle devices, solutions for cell and gene therapies, and taking a novel electromechanical delivery system through development into the clinic.
